Kiwi, To the best of my knowledge you are correct. I just responded to postes with what I find confusing. We are conserving money by slashing advertising. At the same time we have retained our sales force. This does not paint a clear picture of short term intent. KM may have a different focus for advertising. Something I/we haven't stumbled across yet. A few months back I saw that Amarin direct was implemented in the US. Perhaps he intends to focus on a more modern and cost effective form of advertising. I just don't know. Sleven,
I believe it's more "state rules" dependent. I have Aetna/Express scripts and the term gV has never been mentioned to me and there is no special msg on the prescription regarding CVD. Yet others in other states with Express scripts have had gV issues.
Market Data 
Markets 
AI
